STERIS Corp. (STE) Issues FY15 Earnings Guidance
STERIS Corp. (NYSE:STE) issued an update on its FY15 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.78-2.91 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.86, Stock Ratings Network reports. The company issued revenue guidance of +15-17% to ~$1.86-1.89 billion, compared to the consensus revenue estimate of $1.88 billion.
STERIS Corp. (NYSE:STE) traded down 0.20% on Tuesday, hitting $51.2872. 33,805 shares of the company’s stock traded hands. STERIS Corp. has a 1-year low of $39.90 and a 1-year high of $55.36. The stock has a 50-day moving average of $53.07 and a 200-day moving average of $49.94. The company has a market cap of $3.030 billion and a P/E ratio of 23.68.
STERIS Corp. (NYSE:STE) last released its earnings data on Tuesday, August 5th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.54. The company had revenue of $412.60 million for the quarter, compared to the consensus estimate of $418.26 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that STERIS Corp. will post $2.86 EPS for the current fiscal year.
On a related note, analysts at JMP Securities raised their price target on shares of STERIS Corp. from $50.00 to $58.00 in a research note on Friday, May 9th.
STERIS Corporation (NYSE:STE) is a provider of infection prevention and surgical products and services, focused on healthcare, pharmaceutical and research.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.